Researches

Displaying 501 - 510 of 3943
# Title Department Research Year
501 Combining acetyl salicylic acid and rofecoxib into novel oral tablets normalize platelet function with potential higher tolerability in patients with cardiovascular disorders Department of Pharmaceutical Analytical Chemistry 2020
502 Combining acetyl salicylic acid and rofecoxib into novel oral tablets normalize platelet function with potential higher tolerability in patients with cardiovascular disorders Department of Industrial Pharmacy 2020
503 Combining acetyl salicylic acid and rofecoxib into novel oral tablets normalize platelet function with potential higher tolerability in patients with cardiovascular disorders Department of Industrial Pharmacy 2020
504 Combining acetyl salicylic acid and rofecoxib into novel oral tablets normalize platelet function with potential higher tolerability in patients with cardiovascular disorders Department of Pharmaceutical Analytical Chemistry 2020
505 Conjugation of 4-aminosalicylate with thiazolinones afforded non-cytotoxic potent in vitro and in vivo anti-inflammatory hybrids Department of Pharmaceutical Organic Chemistry 2020
506 Cytotoxic Activity of Abietane-Type Diterpenes Isolated From Taxodium distichum Against Cancer Cells Adapted to Nutrient-Starved Conditions Department of Pharmacognosy 2020
507 Design and synthesis of new 1,6-dihydropyrimidin-2-thio derivatives targeting VEGFR-2: Molecular docking and antiproliferative evaluation Department of Pharmaceutical Organic Chemistry 2020
508 Design and synthesis of new pyranoquinolinone heteroannulated to triazolopyrimidine of potential apoptotic antiproliferative activity Department of Pharmaceutical Organic Chemistry 2020
509 Design and synthesis of novel 2,3-dihydropyrazino[1,2-a]indole-1,4-dione derivatives as antiproliferative EGFR and BRAFV600E dual inhibitors Department of Pharmaceutical Organic Chemistry 2020
510 Design and synthesis of novel 2,3-dihydropyrazino[1,2-a]indole-1,4-dione derivatives as antiproliferative EGFR and BRAFV600E dual inhibitors Department of Pharmaceutical Organic Chemistry 2020